Health Care Forum
September 29th 2015 • Boston, MA
Through The Economist's distinct lens of rigorous
analysis and foresight, The Health Care Forum: War on Cancer event will
explore the role of collaboration and integration in driving innovation
and progress in cancer care. This event will focus on innovative
approaches and solutions across policy and financing, prevention, early
detection, treatment and long-term management of this deadly disease.
Join the #WarOnCancer conversation.
New weapons are emerging in the war on cancer thanks to
breakthroughs in science, cutting-edge technologies, more efficient
regulation and most of all, a growing appetite for cooperation within
the sprawling health-care ecosystem. According to the International
Agency for Research on Cancer, the world spends about $320 billion on
cancer treatment and prevention each year. But, according to this group,
half of all cancer deaths could be avoided if that money were spent
more wisely.
Oncology drugs development is getting more expensive and challenging.
Many argue that the bureaucratic and risk-averse business of cancer
research remains a major obstacle to winning the war. Collaboration in
the health-care space is imperative if we are to reach our full
potential to truly unleash innovation, efficiency and
patient-centricity.
That’s why the oncology space remains a huge area of opportunity and
growth. The reality of big data has provided hope that massive data sets
may help both companies and researchers synthesize patient information
to allow for a more targeted approach for new drugs and diagnostics and
that it will help clinicians share information about therapeutic
outcomes. Indeed, it will take unprecedented collaboration among
pharmaceutical companies, hospitals, regulators, patient care advocates
and insurers to scale innovation and drive down costs.
Health Care Forum
September 29th 2015 • Boston, MA
Through The Economist's distinct lens of rigorous
analysis and foresight, The Health Care Forum: War on Cancer event will
explore the role of collaboration and integration in driving innovation
and progress in cancer care. This event will focus on innovative
approaches and solutions across policy and financing, prevention, early
detection, treatment and long-term management of this deadly disease.
Join the #WarOnCancer conversation.
Join the #WarOnCancer conversation.
New weapons are emerging in the war on cancer thanks to
breakthroughs in science, cutting-edge technologies, more efficient
regulation and most of all, a growing appetite for cooperation within
the sprawling health-care ecosystem. According to the International
Agency for Research on Cancer, the world spends about $320 billion on
cancer treatment and prevention each year. But, according to this group,
half of all cancer deaths could be avoided if that money were spent
more wisely.
Oncology drugs development is getting more expensive and challenging. Many argue that the bureaucratic and risk-averse business of cancer research remains a major obstacle to winning the war. Collaboration in the health-care space is imperative if we are to reach our full potential to truly unleash innovation, efficiency and patient-centricity.
That’s why the oncology space remains a huge area of opportunity and growth. The reality of big data has provided hope that massive data sets may help both companies and researchers synthesize patient information to allow for a more targeted approach for new drugs and diagnostics and that it will help clinicians share information about therapeutic outcomes. Indeed, it will take unprecedented collaboration among pharmaceutical companies, hospitals, regulators, patient care advocates and insurers to scale innovation and drive down costs.
Oncology drugs development is getting more expensive and challenging. Many argue that the bureaucratic and risk-averse business of cancer research remains a major obstacle to winning the war. Collaboration in the health-care space is imperative if we are to reach our full potential to truly unleash innovation, efficiency and patient-centricity.
That’s why the oncology space remains a huge area of opportunity and growth. The reality of big data has provided hope that massive data sets may help both companies and researchers synthesize patient information to allow for a more targeted approach for new drugs and diagnostics and that it will help clinicians share information about therapeutic outcomes. Indeed, it will take unprecedented collaboration among pharmaceutical companies, hospitals, regulators, patient care advocates and insurers to scale innovation and drive down costs.
Health Care Forum
Speakers & Agenda
Bahija Jallal
Bahija Jallal, Executive vice-president, Astrazeneca and head, MedImmune
Bahija Jallal, Executive vice-president, Astrazeneca and head, MedImmune
Otis Brawley
Chief medical and scientific officer, executive vice-president of research, American Cancer Society
Chief medical and scientific officer, executive vice-president of research, American Cancer Society
Edward Trimble
Director, center for global health, National Institutes of Health
Director, center for global health, National Institutes of Health
Jennifer Malin
Vice-president, clinical strategy, Anthem, Inc.
Vice-president, clinical strategy, Anthem, Inc.
John Menna
Vice-president, global strategy, healthcare logistics, UPS
Vice-president, global strategy, healthcare logistics, UPS
Kevin T. Conroy
Chairman and chief executive, Exact Sciences
For information on event speaking opportunities, please email eventspeakers@economist.com.
Health Care Forum
Chairman and chief executive, Exact Sciences
For information on event speaking opportunities, please email eventspeakers@economist.com.
Health Care Forum
Why attend?
The Health Care Forum is a full-day conference designed for
leaders in the health-care field to discuss the opportunities and
challenges ahead for the health-care system with a focus on cancer. The
event provides attendees with an ideal forum for networking and
discovering the latest industry developments, while bringing together
cross-sector stakeholders into dialogue on cancer.
The Health Care Forum is a full-day conference designed for
leaders in the health-care field to discuss the opportunities and
challenges ahead for the health-care system with a focus on cancer. The
event provides attendees with an ideal forum for networking and
discovering the latest industry developments, while bringing together
cross-sector stakeholders into dialogue on cancer.
Who you'll meet
- Chief executive officers
- Chief financial officers
- Chief operating officers
- Chief medical officers
- Chief quality officers
- Chief strategy officers
- Chief medical information officers
- Medical directors
- Heads of research and development
- Vice-presidents
- Oncologists
- Business development executives
- Public health executives
- Insurance providers
- Consultants
- Lawyers
- Leading cancer researchers and doctors
- Chief executive officers
- Chief financial officers
- Chief operating officers
- Chief medical officers
- Chief quality officers
- Chief strategy officers
- Chief medical information officers
- Medical directors
- Heads of research and development
- Vice-presidents
- Oncologists
- Business development executives
- Public health executives
- Insurance providers
- Consultants
- Lawyers
- Leading cancer researchers and doctors
Featured topics
- The economics of global cancer care
- Re-inventing patient centered cancer care
- Improving the business of cancer research
- Data sharing: Can cancer be cured in real time?
- New payment models for lowering costs
- Shaping regulation for innovation in treatment
- Finding market gaps: From prevention to diagnosis, what solutions are most scalable?
- Case studies on collaborative efforts that improved outcomes and lowered
- The economics of global cancer care
- Re-inventing patient centered cancer care
- Improving the business of cancer research
- Data sharing: Can cancer be cured in real time?
- New payment models for lowering costs
- Shaping regulation for innovation in treatment
- Finding market gaps: From prevention to diagnosis, what solutions are most scalable?
- Case studies on collaborative efforts that improved outcomes and lowered
